이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Development and Preliminary Validation of a Perioperative Pulmonary Rehabilitation Nursing System for Patients With Craniocerebral Tumors

2026년 4월 30일 업데이트: Haiyan Qiu, The Affiliated Brain Hospital of Nanjing Medical University

Title of Study:

A New Nursing System to Help Lung Recovery After Brain Tumor Surgery

Why was this study done? After surgery for a brain tumor (craniocerebral tumor), some patients develop lung problems like pneumonia or collapsed lung areas (atelectasis). These problems can slow down recovery, keep patients in the hospital longer, and make them feel worse. Doctors and nurses wanted to find a better way to protect the lungs and help patients breathe easier after surgery.

What did the researchers want to find out? They wanted to see if a special, step-by-step nursing system for lung recovery-called the Perioperative Pulmonary Rehabilitation Nursing System (PPRNS) -could reduce lung problems after brain tumor surgery and help patients get back on their feet faster.

What was done in the study?

Who: 165 patients having brain tumor surgery at one hospital.

How: Patients were put into two groups by chance (like flipping a coin):

Control group (81 patients): Received regular, standard care after surgery.

Intervention group (84 patients): Received the new PPRNS care. This included:

Before surgery: Breathing exercises, learning to cough effectively, and nutrition advice.

During surgery: Lung-protective methods by the anesthesia team.

After surgery: Deep breathing exercises, sitting up and moving early, help clearing mucus from the lungs, and close monitoring.

What was measured: The main thing measured was how many patients developed lung problems (like pneumonia) within 14 days after surgery. They also checked lung function, how fast patients recovered (walking, eating, removing tubes), length of hospital stay, and patient satisfaction.

What were the main results?

Fewer lung problems: Only 4.8% of patients in the new care group developed lung complications, compared to 13.6% in the regular care group. This means the new system cut lung problems by more than half.

Better breathing: Patients in the new care group had stronger lung function tests (FVC, PEF) and higher oxygen levels after surgery.

Faster recovery: They got off breathing tubes earlier, started walking sooner, cou

연구 개요

상태

완전한

연구 유형

중재적

등록 (실제)

165

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Jiangsu
      • Nanjing, Jiangsu, 중국, 210029
        • The Affiliated Brain Hospital of Nanjing Medical University

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

아니

설명

Inclusion Criteria:

  • Age 18 to 75 years, inclusive

Preoperative diagnosis of intracranial tumor confirmed by imaging and/or pathology per WHO Classification of Tumours of the Central Nervous System (5th edition), with planned craniotomy for tumor resection (initial or recurrent surgery)

Preoperative assessment confirms ability to cooperate with pulmonary rehabilitation training (adequate consciousness, cognition, and communication for short-term training)

Voluntary participation with written informed consent

Exclusion Criteria:

  • Pre-existing severe chronic obstructive pulmonary disease (COPD GOLD stages 3-4)

Pre-existing severe interstitial lung disease

Requirement for long-term oxygen therapy

Pneumonia or respiratory failure requiring mechanical ventilation within one month prior to surgery

Severe cardiac dysfunction (New York Heart Association class III-IV)

Other major organ insufficiency

Severe impairment of consciousness

Inability to follow commands

Language barriers

Life expectancy less than 30 days

Concurrent participation in other interventional studies that could confound pulmonary function outcomes

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 지지 요법
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: 중재 그룹
The intervention group received a comprehensive PPRNS, including preoperative respiratory training, postoperative exercises, early mobilization, and multidisciplinary care.
간섭 없음: 대조군

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Incidence of Postoperative Pulmonary Complications (PPCs)
기간: Within 14 days post-surgery

Description: The occurrence of respiratory system-related complications, including but not limited to:

Pneumonia (diagnosed based on clinical symptoms, laboratory findings, and radiographic evidence: fever, purulent sputum, pulmonary rales, new infiltrates on chest X-ray or CT)

Atelectasis (confirmed radiographically)

Severe hypoxemia requiring intervention

Airway spasm

Aspiration

Within 14 days post-surgery

2차 결과 측정

결과 측정
측정값 설명
기간
Forced Vital Capacity (FVC)
기간: Preoperative, postoperative day 1, and postoperative day 14 (or hospital discharge)
Assessed via portable spirometry. Expressed in liters (L).
Preoperative, postoperative day 1, and postoperative day 14 (or hospital discharge)
Recovery Metrics (Functional Recovery Indicators)
기간: From surgery end until achievement (measured in hours or days)
Surgery end through extubation, assessed up to 72 hours Surgery end through first effective cough, assessed up to 7 days Surgery end through first standing/walking, assessed up to 14 days Surgery end through catheter removal, assessed up to 14 days Surgery end through first oral intake, assessed up to 14 days
From surgery end until achievement (measured in hours or days)
Postoperative Length of Hospital Stay
기간: At hospital discharge, assessed through study completion (average of 14 days)
Time from surgery date to hospital discharge meeting clinical criteria. Measured in days.
At hospital discharge, assessed through study completion (average of 14 days)
Incidence of Other (Non-Pulmonary) Complications
기간: Within 14 days post-surgery

Intracranial hematoma

Worsened cerebral edema

Neurological deterioration

Deep vein thrombosis (DVT)

Surgical site infection

Within 14 days post-surgery
Postoperative Length of Hospital Stay
기간: At hospital discharge, assessed through study completion (average of 14 days post-surgery)
Time from surgery date to hospital discharge meeting clinical criteria. Measured in days.
At hospital discharge, assessed through study completion (average of 14 days post-surgery)
Patient Satisfaction with Nursing Care
기간: At hospital discharge (average of 14 days post-surgery)
Patient satisfaction with perioperative nursing care measured using a 100-point satisfaction scale (0 to 100 points). Higher scores indicate greater satisfaction (better outcome). Note: This is a non-validated satisfaction scale designed for this study.
At hospital discharge (average of 14 days post-surgery)
Peak Expiratory Flow (PEF)
기간: Preoperative, postoperative day 1, and postoperative day 14 (or hospital discharge)
Measured by a peak flow meter. Expressed in liters per minute (L/min).
Preoperative, postoperative day 1, and postoperative day 14 (or hospital discharge)
Peripheral Oxygen Saturation (SpO₂)
기간: Preoperative, postoperative day 1, and postoperative day 3
Measured at rest on room air. Expressed as percentage (%).
Preoperative, postoperative day 1, and postoperative day 3
Barthel Index Score
기간: At hospital discharge (average of 14 days post-surgery)
Barthel Index assesses functional independence in activities of daily living. Total score ranges from 0 to 100. Higher scores indicate better functional independence (better outcome).
At hospital discharge (average of 14 days post-surgery)
36-Item Short Form Health Survey (SF-36) Total Score
기간: At hospital discharge (average of 14 days post-surgery)
SF-36 assesses health-related quality of life. Total score ranges from 0 to 100. Higher scores indicate better quality of life (better outcome).
At hospital discharge (average of 14 days post-surgery)
Forced Vital Capacity (FVC)
기간: Preoperative, postoperative day 1, and postoperative day 14 (or at hospital discharge)
Assessed via portable spirometry. Measured in liters (L).
Preoperative, postoperative day 1, and postoperative day 14 (or at hospital discharge)
Time to First Ambulation
기간: From surgery end to first ambulation, assessed up to 14 days post-surgery
Time from surgery end to first standing or walking with or without assistance. Measured in hours.
From surgery end to first ambulation, assessed up to 14 days post-surgery
Time to First Effective Autonomous Cough
기간: From surgery end to first effective cough, assessed up to 7 days post-surgery
Time from surgery end to first effective cough performed independently by the patient (able to clear secretions). Measured in hours.
From surgery end to first effective cough, assessed up to 7 days post-surgery

기타 결과 측정

결과 측정
측정값 설명
기간
Safety / Adverse Events
기간: Within 14 days post-surgery

Any unplanned respiratory support/reintubation related to the respiratory system

Any adverse events related to the intervention (e.g., falls during early mobilization, injury from respiratory exercises) - not explicitly reported but implied under non-pu

Within 14 days post-surgery

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 2월 5일

기본 완료 (실제)

2025년 12월 7일

연구 완료 (실제)

2025년 12월 16일

연구 등록 날짜

최초 제출

2026년 4월 14일

QC 기준을 충족하는 최초 제출

2026년 4월 30일

처음 게시됨 (실제)

2026년 5월 6일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 5월 6일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 4월 30일

마지막으로 확인됨

2026년 4월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • No. 2026-KY030-01

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다